tiprankstipranks
Advertisement
Advertisement

GB:0RUG Stock Latest News

bioMerieux price target lowered to EUR 100 from EUR 108 at Morgan Stanley
The FlybioMerieux price target lowered to EUR 100 from EUR 108 at Morgan Stanley
2d ago
bioMerieux price target lowered to EUR 100 from EUR 110 at Barclays
PremiumThe Fly
bioMerieux price target lowered to EUR 100 from EUR 110 at Barclays
2M ago
bioMerieux price target lowered to EUR 109 from EUR 112 at Morgan Stanley
PremiumThe Fly
bioMerieux price target lowered to EUR 109 from EUR 112 at Morgan Stanley
2M ago
bioMerieux downgraded to Neutral from Outperform at BNP Paribas
PremiumThe Fly
bioMerieux downgraded to Neutral from Outperform at BNP Paribas
3M ago
bioMerieux price target lowered to EUR 112 from EUR 113 at Morgan Stanley
PremiumThe Fly
bioMerieux price target lowered to EUR 112 from EUR 113 at Morgan Stanley
4M ago
bioMerieux upgraded to Neutral from Underperform at BofA
PremiumThe FlybioMerieux upgraded to Neutral from Underperform at BofA
4M ago
bioMerieux (0RUG) Announces Q2 Dividend: Read On for Important Dates
Premium
Dividends
bioMerieux (0RUG) Announces Q2 Dividend: Read On for Important Dates
1y ago
bioMérieux’s VITEK® COMPACT PRO Gains FDA Approval to Combat Antibiotic Resistance
Premium
Company Announcements
bioMérieux’s VITEK® COMPACT PRO Gains FDA Approval to Combat Antibiotic Resistance
1y ago
bioMérieux Prepares for May 2025 Shareholder Meeting
PremiumCompany Announcements
bioMérieux Prepares for May 2025 Shareholder Meeting
1y ago
bioMérieux Launches Innovative Diagnostic Solution for Food Safety
PremiumCompany Announcements
bioMérieux Launches Innovative Diagnostic Solution for Food Safety
1y ago
bioMérieux Gains FDA Clearance for New Gastrointestinal Panel
PremiumCompany Announcements
bioMérieux Gains FDA Clearance for New Gastrointestinal Panel
1y ago
bioMérieux to Present Strategic Growth Plans at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
bioMérieux to Present Strategic Growth Plans at J.P. Morgan Healthcare Conference
1y ago
bioMérieux Gains FDA Clearance for Tropical Fever Test
PremiumCompany AnnouncementsbioMérieux Gains FDA Clearance for Tropical Fever Test
1y ago
bioMérieux’s Strong Growth Continues in 2024
Premium
Company Announcements
bioMérieux’s Strong Growth Continues in 2024
1y ago
bioMerieux Launches New Vitamin B12 Test
Premium
Company Announcements
bioMerieux Launches New Vitamin B12 Test
2y ago
bioMérieux Reports Voting Rights and Shares
PremiumCompany Announcements
bioMérieux Reports Voting Rights and Shares
2y ago
bioMerieux Reports Strong H1 2024 Growth
PremiumCompany Announcements
bioMerieux Reports Strong H1 2024 Growth
2y ago
bioMerieux Announces Latest Voting Rights Totals
PremiumCompany Announcements
bioMerieux Announces Latest Voting Rights Totals
2y ago
bioMerieux Advances Rapid Diagnostic Testing
PremiumCompany Announcements
bioMerieux Advances Rapid Diagnostic Testing
2y ago
bioMérieux’s VITEK System Wins FDA Clearance
PremiumCompany AnnouncementsbioMérieux’s VITEK System Wins FDA Clearance
2y ago
bioMerieux Reports Voting Rights and Shares
Premium
Company Announcements
bioMerieux Reports Voting Rights and Shares
2y ago
bioMerieux’s New Test to Revolutionize Brain Injury Assessment
Premium
Company Announcements
bioMerieux’s New Test to Revolutionize Brain Injury Assessment
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >